NASDAQ:TRDA | Profit Breakdown | Entrada Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$898,000.00-$44.96M-$42.76M
2026-03-31$875,000.00-$42.3M-$39.72M
2025-12-31$1.3M-$42.21M-$39.16M
2025-09-30$1.61M-$47.05M-$44.13M
2025-06-30$1.95M-$46.85M-$43.1M
2025-03-31$20.56M-$21.79M-$17.35M
2024-12-31$37.4M-$5.87M$1.13M
2024-09-30$19.57M-$21.66M-$14.03M
2024-06-30$94.69M$53.42M$55.03M
2024-03-31$59.12M$21.11M$23.5M
2023-12-31$41.85M$4.91M-$9.54M
2023-09-30$43.74M$14.01M$35.46M
2023-06-30$18.17M-$16.3M-$25.93M
2023-03-31$25.26M-$5.78M-$6.67M
2022-12-31-$25.58M-$24.63M
2022-09-30$0.00-$25.94M-$25.14M
2022-06-30$0.00-$23.58M-$23.18M
2022-03-31$0.00-$22.15M-$21.67M
2021-12-31-$18.46M-$18.45M
2021-09-30-$14.36M-$14.43M
2021-06-30-$9.91M-$9.9M
2021-03-31-$8.39M-$8.38M
2020-12-31-$8.65M-$8.67M
2020-09-30-$6.97M-$6.99M
2020-06-30-$6.17M
2020-03-31-$4.69M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$25.42M-$157.9M-$143.75M
2024-12-31$210.78M$47.01M$65.63M
2023-12-31$129.01M-$3.16M-$6.69M
2022-12-31-$97.25M-$94.62M
2021-12-31-$51.13M-$51.16M
2020-12-31-$26.67M-$26.52M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.